The dynamics of prostate specific antigen during watchful waiting of prostate carcinoma: a study of 94 Japanese men (Q77839118)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11920530%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

title

The dynamics of prostate specific antigen during watchful waiting of prostate carcinoma: a study of 94 Japanese men (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11920530%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

Robin T Vollmer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11920530%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Shin Egawa

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11920530%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Sadahito Kuwao

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11920530%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Shiro Baba

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11920530%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 March 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11920530%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11920530%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11920530%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11920530%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

1692-1698

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11920530%20AND%20SRC:MED&resulttype=core&format=json

Serum prostate-specific antigen: the most useful tumor marker

8 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10443

Results of radical prostatectomy in men with clinically localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10443

Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10443

Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10443

The natural history of clinical prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10443

Results of conservative management of clinically localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10443

Deferred treatment of clinically localized low-grade prostate cancer: actual 10-year and projected 15-year follow-up of the Karolinska series

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10443

Long-term Survival Among Men With Conservatively Treated Localized Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10443

Outcome research after radical retropubic prostatectomy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10443

Observations on the doubling time of prostate cancer.The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volume

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10443

Watchful waiting or watchful progression?: Prostate specific antigen doubling times and clinical behavior in patients with early untreated prostate carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10443

Serial prostate specific antigen measurements and progression in untreated confined (stages T0 to 3NxM0, grades 1 to 3) carcinoma of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10443

The dynamics of prostate specific antigen in hormone refractory prostate carcinoma: an analysis of cancer and leukemia group B study 9181 of megestrol acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10443

Histologic grading of prostate cancer: a perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10443

Linear regressive analysis using prostate-specific antigen doubling time for predicting tumor biology and clinical outcome in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10443

Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial of the National Cancer Institute

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10443

inferred from DOI database lookup

7 January 2021

based on heuristic

Generalized Linear Models

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10443

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CNCR.10443

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11920530%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11920530%20AND%20SRC:MED&resulttype=core&format=json